BUSINESS● LOW3h ago · Oct 30, 2026, 8:57 AM
AstraZeneca Q3 profit beats estimates as cancer drug sales drive growth
Seeking Alpha Tech · global
AstraZeneca's third-quarter profit exceeded estimates, driven by strong sales of its cancer drugs. This highlights the company's financial performance and the impact of its oncology portfolio on growth.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS25m agoCanadian National Railway Non-GAAP EPS of C$2.16 beats by C$0.08, revenue of C$4.77B beats by C$120MSeeking Alpha TechBUSINESS25m agoExxon rises after posting Q3 earnings topper on record refining haulSeeking Alpha Tech